In regions with a large animal production sector, the viruses that cause these diseases - of the genus Morbillivirus - have significant repercussions on the local economy and food security: in Senegal, the economic impact of a peste des petits ruminants focus was estimated in 1996 at 80 000 euros over three months.
Rinderpest affects domestic cattle, buffaloes and yaks, but also sheep, goats and some pig races, along with a whole range of wild species. Despite a sustained blanket preventive vaccination campaign that has almost wiped out the disease on a global level, there are still some persistent infection foci in the Somali ecosystem. And there is no cure. As regards peste des petits ruminants, which affects sheep and goats, it is found in Africa, on the Arabian Peninsula, in the Middle East and in India. The available preventive vaccines are effective, but still have some drawbacks, such as their low heat resistance. There is no therapeutic treatment against this disease either.
Since early 2005, CIRAD has been developing a new control method against these diseases, based on a novel technique derived from molecular genetics. This new approach centres on a natural biological mechanism: "RNA interference", which usually allows multicellular organisms to control the level of expression of some of their genes. The process involves short RNA fragments capable of preventing the reading and translation into proteins of the genetic code carried by DNA: the fragments are known as interfering RNA. They prevent the RNA playing its fundamental role as a messenger of the information contained in the genes with a view to protein production. In effect, so-called interfering RNA links specifically to the target messenger RNA, resulting in the latter's deterioration and consequently inhibiting expression of the corresponding protein.
Interfering RNA inhibits more than 80% of virus replication
CIRAD researchers have recently identified three synthetic interfering RNAs capable of inhibiting more than 80% of peste des petits ruminants and rinderpest virus replication in vitro. They are targeted at the messenger RNA of the nucleoprotein gene of the viruses that cause the diseases, blocking the virus multiplication process. An application was made for a patent on the results concerning these new biological antivirals in December 2005.
The second phase of the research has now begun: in vivo tests of the new generation of antivirals on infected animals. To this end, the plan is to transfer the interfering RNA to infected animals through a viral vector generally used as a vaccine. If this is indeed seen to inhibit virus replication in the diseased animals, this would open the way for the development of therapeutic vaccines against rinderpest and peste des petits ruminants. The work is due to last for five years, and should make it possible to provide farmers with a safe, effective vaccine.
The results look very promising, and open up vast prospects in terms of animal health. They could be of interest for other viruses such as bird flu or African swine fever. For this last disease, using RNA interference as a control method would be a major step forward, as there is not currently any preventive vaccine.
Helen Burford | alfa
Alkaline soil, sensible sensor
03.08.2017 | American Society of Agronomy
New 3-D model predicts best planting practices for farmers
26.06.2017 | Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign
Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.
As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...
Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.
Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...
For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.
While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...
An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.
The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...
A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.
Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...
16.08.2017 | Event News
04.08.2017 | Event News
26.07.2017 | Event News
22.08.2017 | Health and Medicine
22.08.2017 | Materials Sciences
22.08.2017 | Life Sciences